The geopolitics of vaccine diplomacy in the Middle East

As demand for vaccines surges across the Middle East and North Africa, China and Russia have seen an opportunity to push their own products as a diplomatic tool in the region, in competition with the United States. Beijing’s production of its own vaccines, through its companies Sinopharm and Sinovac, aims to further its Covid-19 diplomacy and act as a counterweight to Western alternatives, including the US-based Moderna vaccine, the German American company Pfizer and the British-Dutch Oxford-AstraZeneca vaccine. China has aimed to supply its vaccines across Asia and elsewhere in the world, lik…

Read More

HEDGE accordingly